NunaBio Limited
Synthetic DNA production for cutting-edge biotechnology solutions.
Synthetic DNA production for cutting-edge biotechnology solutions.
NunaBio Limited is a biotechnology startup founded in 2021, based in the United Kingdom. The company specializes in synthetic DNA production for cutting-edge biotechnology solutions. NunaBio is involved in Contract Research Organizations (CRO) and Contract Development and Manufacturing Organization (CDMO) activities. The company has garnered attention for its R&D flexibility and innovative approach to complex and challenging projects. NunaBio's last investment was a £1.90M Seed Round at 20 April 2023, with contributions from Martlet Capital, Ascension Life Fund, Pioneer Group, and the North East Innovation Fund. NunaBio's core expertise lies in research and development into cell-free DNA synthesis, process optimization, route design, scale-up, and small-scale manufacture for clinical studies.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | £1.90M | 4 |
|
20 Apr 2023 |
No recent news or press coverage available for NunaBio Limited.
We care about your data, and we'd love to use cookies make your experience better.